Literature DB >> 2310304

A host-cell-selected variant of influenza B virus with a single nucleotide substitution in HA affecting a potential glycosylation site was attenuated in virulence for volunteers.

J S Oxford1, G C Schild, T Corcoran, R Newman, D Major, J Robertson, J Bootman, P Higgins, W al-Nakib, D A Tyrrell.   

Abstract

An influenza B virus was passaged in man (virus A) and then in human embryo trachea (C) and into embryonated eggs (D) or directly into eggs (B). Virus A, B, and C had the same (cell-like) haemagglutinin phenotype on reaction with selected monoclonal antibodies while D had an "egg-like" phenotype. The viruses were administered at a dose of 1,000 TCD50 (for MDCK cells) by intranasal inoculation to groups of 27 or 28 volunteers. Viruses A, B, and C all produced disease in six to eight volunteers, whereas D produced no illness and only four volunteers were infected. The viruses shed by the volunteers were indistinguishable from those with which they were inoculated. The haemagglutinin genes of the viruses were sequenced and changes were detected indicating amino acid substitutions at position 196-198 in the attenuated egg-grown virus D whereby a potential glycosylation site present in the other viruses was lost.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310304     DOI: 10.1007/bf01310701

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Analysis of antigenic determinants on internal and external proteins of influenza virus and identification of antigenic subpopulations of virions in recent field isolates using monoclonal antibodies and immunogold labelling.

Authors:  S Patterson; J S Oxford
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.

Authors:  J M Wood; J S Oxford; U Dunleavy; R W Newman; D Major; J S Robertson
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

3.  Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus.

Authors:  J S Robertson; J S Bootman; R Newman; J S Oxford; R S Daniels; R G Webster; G C Schild
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

4.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes.

Authors:  M Krystal; R M Elliott; E W Benz; J F Young; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

Authors:  J S Robertson; C W Naeve; R G Webster; J S Bootman; R Newman; G C Schild
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

7.  Evidence for host-cell selection of influenza virus antigenic variants.

Authors:  G C Schild; J S Oxford; J C de Jong; R G Webster
Journal:  Nature       Date:  1983 Jun 23-29       Impact factor: 49.962

8.  Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK).

Authors:  J S Oxford; T Corcoran; R Knott; J Bates; O Bartolomei; D Major; R W Newman; P Yates; J Robertson; R G Webster
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

  9 in total
  9 in total

1.  Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety.

Authors:  M Ohuchi; R Ohuchi; A Feldmann; H D Klenk
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.

Authors:  I V Alymova; S Kodihalli; E A Govorkova; B Fanget; C Gerdil; R G Webster
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  The roles of hemagglutinin Phe-95 in receptor binding and pathogenicity of influenza B virus.

Authors:  Fengyun Ni; Innocent Nnadi Mbawuike; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

4.  African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

Authors:  E A Govorkova; G Murti; B Meignier; C de Taisne; R G Webster
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  The haemagglutinins of influenza A (H1N1) viruses in the 'O' or 'D' phases exhibit biological and antigenic differences.

Authors:  A Azzi; O Bartolomei-Corsi; K Zakrzewska; T Corcoran; R Newman; J S Robertson; P Yates; J S Oxford
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

6.  Diversifying selective pressure on influenza B virus hemagglutinin.

Authors:  Jun Shen; Brian D Kirk; Jianpeng Ma; Qinghua Wang
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

7.  Crystal structure of unliganded influenza B virus hemagglutinin.

Authors:  Qinghua Wang; Feng Cheng; Mingyang Lu; Xia Tian; Jianpeng Ma
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

Review 8.  A view from the Common Cold Unit.

Authors:  D A Tyrrell
Journal:  Antiviral Res       Date:  1992-06       Impact factor: 5.970

9.  A H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unusual cleavage site.

Authors:  I Günther; B Glatthaar; G Döller; W Garten
Journal:  Virus Res       Date:  1993-02       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.